相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Transmission of Extensively Drug-Resistant Tuberculosis in South Africa
N. Sarita Shah et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Tuberculosis Case Fatality and Other Causes of Death among Multidrug-Resistant Tuberculosis Patients in a High HIV Prevalence Setting, 2000-2008, South Africa
Martie van der Walt et al.
PLOS ONE (2016)
Predictors of mortality and treatment success during treatment for rifampicin-resistant tuberculosis within the South African National TB Programme, 2009 to 2011: a cohort analysis of the national case register
Kathryn Schnippel et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2015)
Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa
M. Loveday et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2015)
Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis
N. Ndjeka et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2015)
WHO's new End TB Strategy
Mukund Uplekar et al.
LANCET (2015)
Mortality among MDR-TB Cases: Comparison with Drug-Susceptible Tuberculosis and Associated Factors
Kocfa Chung-Delgado et al.
PLOS ONE (2015)
Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study
Elize Pietersen et al.
LANCET (2014)
Factors affecting treatment outcomes in drug-resistant tuberculosis cases in the Northern Cape, South Africa
E. Elliott et al.
PUBLIC HEALTH ACTION (2014)
Tuberculosis control in South Africa: Successes, challenges and recommendations
G. J. Churchyard et al.
SAMJ SOUTH AFRICAN MEDICAL JOURNAL (2014)
Duration of Anti-Tuberculosis Therapy and Timing of Antiretroviral Therapy Initiation: Association with Mortality in HIV-Related Tuberculosis
Claudia P. Cortes et al.
PLOS ONE (2013)
Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting
N. R. Gandhi et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2012)
HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era
E. Palacios et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2012)
Delay in commencing treatment for MDR TB at a specialised TB treatment centre in KwaZulu-Natal
R. Narasimooloo et al.
SAMJ SOUTH AFRICAN MEDICAL JOURNAL (2012)
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
D. Falzon et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Extensively Drug-Resistant TB in Eastern Cape, South Africa: High Mortality in HIV-Negative and HIV-Positive Patients
Charlotte L. Kvasnovsky et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2011)
Outcomes of Multi-Drug Resistant Tuberculosis (MDR-TB) among a Cohort of South African Patients with High HIV Prevalence
Jason E. Farley et al.
PLOS ONE (2011)
HIV Coinfection in Multidrug- and Extensively Drug-Resistant Tuberculosis Results in High Early Mortality
Neel R. Gandhi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study
Keertan Dheda et al.
LANCET (2010)
Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis
Neel R. Gandhi et al.
LANCET (2010)
Treatment default and death among tuberculosis patients in Hunan, China
Benjamin Abuaku et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2010)
Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study
C-Y. Chiang et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy
Weerawat Manosuthi et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients:: a national cohort study in Peru
PG Suárez et al.
LANCET (2002)
分享论文
